148 related articles for article (PubMed ID: 3488193)
1. Sensitivity of Branhamella catarrhalis to oral antibiotics.
Kallings I
Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
[TBL] [Abstract][Full Text] [Related]
2. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Forsgren A; Walder M
Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
Renkonen OV
Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of Branhamella catarrhalis.
Schreiner A
Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
Doern GV; Siebers KG; Hallick LM; Morse SA
Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.
Sweeney KG; Verghese A; Needham CA
Antimicrob Agents Chemother; 1985 Apr; 27(4):499-502. PubMed ID: 3873899
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
Riley TV; Digiovanni C; Hoyne GF
J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Doern GV; Chapin KC
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
[TBL] [Abstract][Full Text] [Related]
10. Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
Van Hare GF; Shurin PA; Marchant CD; Cartelli NA; Johnson CE; Fulton D; Carlin S; Kim CH
Rev Infect Dis; 1987; 9(1):16-27. PubMed ID: 3493519
[TBL] [Abstract][Full Text] [Related]
11. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
Shurin PA; Van Hare GF
Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.
Ahmad F; McLeod DT; Croughan MJ; Calder MA
Antimicrob Agents Chemother; 1984 Sep; 26(3):424-5. PubMed ID: 6508272
[TBL] [Abstract][Full Text] [Related]
13. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
Calder MA; Croughan MJ; McLeod DT; Ahmad F
Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of roxithromycin against Moraxella catarrhalis.
Spencer RC; Wheat PF
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):63S-65S. PubMed ID: 1617926
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
18. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of Ro-15-8074, a new oral cephalosporin.
Peeters M; Piot P
J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719
[TBL] [Abstract][Full Text] [Related]
20. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
Nicotra B; Rivera M; Luman JI; Wallace RJ
Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
